Sjögren's syndrome is a common autoimmune disease (affecting ~0.7% of European Americans) that typically presents as keratoconjunctivitis sicca and xerostomia. Here we report results of a large-scale association study of Sjögren's syndrome. In addition to strong association within the human leukocyte antigen (HLA) region at 6p21 (P meta = 7.65 × 10 −114 ), we establish associations with IRF5-TNPO3 (P meta = 2.73 × 10 −19 ), STAT4 (P meta = 6.80 × 10 −15 ), IL12A (P meta = 1.17 × 10 −10 ), FAM167A-BLK (P meta = 4.97 × 10 −10 ), DDX6-CXCR5 (P meta = 1.10 × 10 −8 ) and TNIP1 (P meta = 3.30 × 10 −8 ). We also observed suggestive associations (P meta < 5 × 10 −5 ) with variants in 29 other regions, including TNFAIP3, PTTG1, PRDM1, DGKQ, FCGR2A, IRAK1BP1, ITSN2 and PHIP, among others. These results highlight the importance of genes that are involved in both innate and adaptive immunity in Sjögren's syndrome.
A r t i c l e s Sjögren's syndrome is a common (affecting ~0.7% of European Americans 1 ) chronic autoimmune condition that is characterized by exocrine gland dysfunction and results in substantial morbidity. Females are affected at a rate of approximately ten times that of males 2, 3 . Although affected individuals are identified clinically by oral and ocular manifestations, the full disease spectrum may encompass a complex myriad of systemic features, making diagnosis clinically challenging 4 . Current American-European Consensus Group classification criteria require either the presence of autoantibodies to Ro and/or La or histologic evidence of inflammation within the salivary glands, in addition to other subjective and objective measures of keratoconjunctivitis sicca and xerostomia 5 . Therapeutic options are primarily palliative and do little to prevent irreversible exocrine gland damage 6 .
The pathophysiology of Sjögren's syndrome includes concurrent dysregulation of innate and adaptive immune pathways involving both cell-mediated and humoral disease processes that are incompletely understood 7 . Labial salivary gland and peripheral blood gene-expression microarray studies have demonstrated dysregulation of type I interferon-inducible genes 8, 9 . Although previous work in Sjögren's syndrome genetics has been limited to candidate gene studies, strong association with genes encoding several human HLA molecules, including HLA-DR, HLA-DQB1 and HLA-DQA1, has been established 10, 11 . Several non-HLA regions have been implicated in the disease [12] [13] [14] [15] , including IRF5 and STAT4; however, none of these associations has exceeded the genomewide significant (GWS) threshold of P = 5 × 10 −8 ( Supplementary  Table 1 ). Here we used genome-wide association and large-scale Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome A r t i c l e s replication approaches to identify new risk loci in a case-control study of primary Sjögren's syndrome.
RESULTS

Study overview
To maximize the power of our study, we formed the Sjögren's Genetics Network (SGENE), a collaborative research effort comprising multiple international sites ( Supplementary Fig. 1 and Supplementary Table 2 ). Data set 1 (DS1) included 395 individuals with Sjögren's syndrome (cases) and 1,975 population controls of European descent after implementing quality control (QC; Online Methods and Supplementary Table 2 ). We genotyped these individuals using the Illumina Omni1-Quad array. Data set 2 (DS2) consisted of 1,243 cases and 4,779 population controls genotyped on the Illumina ImmunoChip, and data set 3 (DS3) included 1,158 cases and 3,071 population controls genotyped on a supplemental custom array designed to include variants not present on the ImmunoChip (all of the individuals in DS2 and DS2 were of European descent and were included after QC; Supplementary  Fig. 1b ). Data set 4 (DS4) evaluated 1,541 cases and 2,634 population controls genotyped on the Illumina ImmunoChip, focusing on variants exclusive to DS4 and not common between DS1 and DS2 ( Supplementary Fig. 1b ). We performed imputation in regions with P < 5 × 10 −5 to increase the number of overlapping variants available for analysis ( Supplementary Fig. 1c,d) .
HLA region
The HLA region at 6p21 was the only association that exceeded the GWS threshold of P < 5 × 10 −8 in DS1 (Supplementary Fig. 2) . After imputation, we found the peak effect at rs112357081 near HLA-DRA with P DS1 = 1.01 × 10 −32 ( Table 1 and Supplementary Fig. 3) . We observed no inflation in the test statistic (λ GC = 1.0) and no significant deviation from the expected distribution of P values after removing the HLA region ( Supplementary Fig. 4) . After meta-analysis between imputed DS1 and DS2 ( Figs. 1 and 2 and Supplementary Fig. 1) , there was a strong association spanning a region that included the HLA class I, III and II loci ( Fig. 2a and Supplementary Table 3) , with a peak association observed 5′ of HLA-DQB1 in the HLA class II region at rs115575857 with P meta = 7.65 × 10 −114 ( Table 1 and Fig. 2a ). We also identified a second set of variants not in linkage disequilibrium (LD) with rs115575857 that peaked at rs116232857 (P meta = 1.33 × 10 −96 ; Table 1 and Fig. 2a ).
Further dissection through logistic regression analysis in DS2 adjusting for rs115575857 identified an ~5-Mb haplotype encompassing the extended HLA region (Supplementary Fig. 5 ). In addition, we observed a narrow region of residual association tagged by rs116232857 (P residual = 7.00 × 10 −26 ) in the HLA-DRA through HLA-DQA1 regions (Supplementary Fig. 5 ). Logistic regression adjusting for rs115575857 and rs116232857 accounted for most of the association within the HLA region (the residual association in the region at rs115146037 went from 10 −80 to 10 −9 after adjustment; Supplementary Fig. 5 ), thus identifying the presence of at least two independent effects.
We imputed classical HLA alleles into DS1 and DS2 to better understand the relationship between the HLA variants tested in this study and those reported previously. The top associated classical allele was HLA-DQB1*0201 (P meta = 1.38 × 10 −95 ), which was followed closely by HLA-DQA1*0501 (P meta = 8.50 × 10 −94 ; Supplementary Table 4 and Supplementary Fig. 6 ). We used logistic regression, adjusting for both the top associated classical HLA alleles and the variants identified through the meta-analysis of DS1 and DS2. As previously described 16 , our data show that HLA-DQB1*0201, HLA-DQA1*0501 and HLA-DRB1*0301 are in strong LD (r 2 > 0.97), and adjusted logistic regression using any of the three alleles accounted for the observed association. Moreover, each of these classical alleles accounted for the association at rs115575857. Likewise, rs115575857 explained the association at each of the three classical alleles ( Supplementary  Fig. 6 ). Adjusting for rs116232857 could account for the association at HLA-DQB1*0501, which has been previously reported as a protective allele in Sjögren's syndrome 11 . However, HLA-DQB1*0501 could not account for the association observed at rs116232857, suggesting that rs116232857 better tags the functional effect(s) than the classical allele.
Enrichment analysis using all variants with P meta < 5 × 10 −5 identified a statistically significant association of disease-associated variants within 100 bp of regions found to be crosslinked to the transcription Figure 1 Summary of genome-wide association results for 27,501 variants overlapping between DS1 and DS2 after imputation and metaanalysis. The −log 10 P value for each variant is plotted according to chromosome and base-pair position. Seven loci (red) exceeded the GWS of P meta < 5 × 10 −8 (red dashed line). The suggestive threshold (P meta < 5 × 10 −5 ) is indicated by a blue dashed line. 17 . In total, 161 variants contributed to the enrichment in DS2, with all but one variant being located in the HLA region. To further evaluate the influence of the extensive LD in the HLA, we tested for enrichment of Sjögren's syndromeassociated variants in RFX5 ChIP-seq peaks using only the variants in the HLA region that were present in DS1 as the background, and we continued to observe significant enrichment (P = 9.24 × 10 −7 ; Supplementary Table 5 ).
To evaluate the functional mechanism of this RFX5 enrichment within the HLA, we tested the variants near RFX5 ChIP-seq peaks as expression quantitative trait loci (eQTL), which resulted in several statistically significant results ( Fig. 3a- Table 6 and Supplementary Fig. 7) . We observed the top overall eQTL with rs114846898 and HLA-DRB6 (analysis of variance P (P ANOVA ) = 1.03 × 10 −42 ; Fig. 3a ). We observed a modest eQTL for rs116232857 and HLA-DRB6 (P ANOVA = 1.77 × 10 −12 ); however, we found that rs116232857 and rs114846898 were in nearly perfect LD with each other (D′ = 0.98), suggesting that the association at rs116232857 might be due to rs114846898. In examining the adjusted analysis results, we found that rs115575857 and rs116232857 could explain rs114846898, but adjusting for rs115575857 and rs114846898 left a residual association (P residual = 9.44 × 10 −7 ) at rs116232857, suggesting that rs116232857 probably tags additional functional variant(s).
e, Supplementary
In addition to the strong association observed in the HLA region, six non-HLA loci surpassed the GWS threshold, including IRF5, STAT4, IL12A, BLK, CXCR5 and TNIP1 ( Table 2 and Fig. 1 ).
IRF5
We observed the most statistically significant association outside the HLA region after meta-analysis in the region of IRF5 (encoding interferon regulatory factor 5). In total, 67 SNPs exceeded the P meta < 5 × 10 −8 threshold, with the peak effect observed in the IRF5 promoter region (rs3757387, P meta = 2.73 × 10 −19 ; Fig. 2b , Supplementary  Table 7 and Supplementary Fig. 8) . A group of variants, tagged by rs17339836 (P meta = 2.43 × 10 −16 ) and spanning IRF5 and TNPO3, were not correlated with the promoter variants ( Fig. 2b) .
Logistic regression adjusting for rs3757387 explained all of the promoter region association, whereas a residual association persisted with variants spanning IRF5-TNPO3 tagged by rs17339836 (P residual = 2.86 × 10 −4 ; Supplementary Fig. 9 ). Moreover, a group of variants tagged by rs6948875 that were not associated in the unadjusted single-marker analysis became statistically significant when adjusting for rs3757387. Adjusting for both rs3757387 and rs17339836 again resulted in residual association of the region tagged by rs6948875 and rs10954213 ( Supplementary Fig. 9 ). Because rs10954213 was statistically significant in the single-marker analysis ( Supplementary Table 7 ), we added this SNP to the model in lieu of rs6948875. Logistic regression models adjusting for rs3757387, rs17339836 and rs10954213 resulted in no residual association in the regions, indicating that three independent effects are likely. Bioinformatics database mining of this region indicated that the associated variants were located within a variety of biologically relevant features encompassing a range of potential functional mechanisms ( Supplementary Fig. 10 ).
STAT4
We observed a statistically significant association exceeding GWS between Sjögren's syndrome and 12 variants, 8 of which fall within the third intron of STAT4 (encoding signal transducer and activator npg of transcription 4), with the peak association located at an insertiondeletion (indel) polymorphism (rs10553577, P meta = 6.80 × 10 −15 ; Fig. 2c , Supplementary Table 8 and Supplementary Figs. 11 and 12) . rs10553577 accounted for the association within the STAT4 region; we observed residual association with rs3024918 (P residual = 2.70 × 10 −4 ) in the promoter region of STAT1, but this association did not surpass our required threshold (P < 1 × 10 −4 ) after adjustment for an independent effect ( Supplementary Fig. 12 ). Bioinformatics databases show numerous transcription factors bound to both regions ( Supplementary Fig. 13) ; however, neither effect resulted in a statistically significant eQTL (data not shown).
IL12A
Seven variants in the IL12A (encoding interleukin-12A) region demonstrated strong association, with the peak association occurring 5.3 kb 3′ of IL12A at rs485497 (P meta = 1.17 × 10 −10 ; Fig. 2d , Supplementary  Table 9 and Supplementary Fig. 14) . Logistic regression analysis adjusting for rs485497 indicated that this variant accounted for all of the observed association ( Supplementary Fig. 15 ). To determine the functional role of the variants that associated between IL12A and Sjögren's syndrome, we performed eQTL analysis for all variants showing evidence of association in the region. Of the variants exceeding GWS, only rs485497 was associated with IL12A transcript npg A r t i c l e s expression; however, seven variants 3′ of IL12A influenced expression more significantly, with the eQTL peaking at rs4680536 ( Fig. 3f and Supplementary Table 6 ). Haplotype analysis of the associated variants at IL12A indicated the presence of only one risk haplotype and the possibility that rs485497 may tag functional variants on either side of this SNP (Supplementary Fig. 15 ), which is supported by the presence of multiple transcription factor binding sites and other regulatory elements in the flanking LD blocks (Supplementary Fig. 16 ).
BLK
A total of 30 variants on chromosome 8 exceeded GWS in the region of FAM167A and BLK (encoding B lyphoid kinase) ( Fig. 2e , Supplementary Table 10 and Supplementary Fig. 17) . We observed the maximum association after meta-analysis in the shared promoter region of FAM167A-BLK at rs2736345 (P meta = 4.97 × 10 −10 ); however, this SNP was not statistically significant in DS1 ( Table 2 ). The second most significant variant after meta-analysis (significant in both DS1 and DS2) was rs2729935 with P meta = 6.85 × 10 −10 , which is located in the first intron of BLK. Logistic regression analysis adjusting for rs2729935 (as this variant was significant in both data sets) indicated a residual association (P residual = 1.75 × 10 −3 ) present at rs2736345. However, adjusting for rs2736345 in the logistic model showed the likely presence of only one effect accounting for all the association in the region (Supplementary Fig. 18 ).
Using expression data for BLK, eQTL analysis of the associated variants identified several with the potential to influence transcript expression, including the top overall SNP in the BLK region, rs2736345 (Supplementary Table 6 ). The most statistically significant eQTL was located in the first intron of BLK at rs2409781 (Fig. 3g) , a variant that is loosely correlated with rs2736345 and rs2729935 (r 2 ≈ 0.5). Evaluation of FAM167A probes with the variants associated with Sjögren's syndrome yielded greater statistical significance than evaluation of BLK probes (Fig. 3h) . Bioinformatics analysis indicated the presence of many transcriptionally relevant markers in not only the shared promoter region but also the first intron of BLK, suggesting the possibility that association in this region affects the transcriptional regulation of BLK and/or FAM167A (Supplementary Fig. 19 ).
CXCR5
We observed association with a variant ~16 kb 5′ of the coding region of CXCR5 (encoding chemokine (C-X-C motif) receptor 5) at rs7119038 (P meta = 1.10 × 10 −8 ; Fig. 2f , Supplementary Table 11 and Supplementary Fig. 20) . Three additional variants also exceeded the GWS threshold, with rs11217033 located ~90 kb 5′ of CXCR5 and ~12 kb 5′ of the neighboring gene, DDX6 (Fig. 2f) . Adjusting for rs7119038 explained all the association signals in this region (Supplementary Fig. 21) . Although no statistically significant eQTLs for CXCR5 were present in the region, bioinformatics analysis indicated the presence of many regulatory elements throughout the region (Supplementary Fig. 22 ). Assessment of eQTLs for DDX6 was not possible, as the probe failed QC in the gene expression study.
TNIP1
In the TNIP1 (encoding TNFAIP3 interacting protein 1) region, one SNP (rs6579837) exceeded GWS with P meta = 3.30 × 10 −8 ; however, 29 additional variants showed evidence of association with P meta < 5 × 10 −5 (Fig. 2g, Supplementary Table 12 and Supplementary Fig. 23 ). Logistic regression analysis adjusting for rs6579837 accounted for all the association observed in the region (Supplementary Fig. 24) . Several of the variants associated with Sjögren's syndrome were also eQTLs for the TNIP1 probe, including rs6579837 ( Supplementary  Table 6 ). However, we observed the most statistically significant eQTL at rs73272842 located in TNIP1, where multiple regulatory elements have been identified ( Fig. 3i and Supplementary Fig. 25 ).
Suggestive associations with Sjögren's syndrome
We identified eight loci that showed suggestive association in the meta-analysis (P meta < 5 × 10 −5 ) but did not surpass the GWS threshold ( Table 3 and Supplementary Fig. 1b ). Twenty-one additional regions surpassed a suggestive threshold for significance (P meta < 5 × 10 −5 ) using DS4 (the variants evaluated were exclusive to DS4; Supplementary Fig. 1b and Supplementary Table 13 ). Further replication of these regions will be needed to determine whether they are bona fide risk loci.
Protein-protein interactions and pathway analysis
To assess the potential effects of associated variants on the underlying biology, we used two bioinformatics tools: the Disease Association Protein-Protein Link Evaluator (DAPPLE) 18 and Genomatix Pathway System (GePS) 19 . DAPPLE defines genomic regions that are in LD with variants achieving GWS or suggestive thresholds to determine any potential protein-protein interaction (PPI) that could elucidate npg the underlying biological perturbations in Sjögren's syndrome. In assessing the GWS variants outside the HLA region only, we observed no direct PPI, and although we observed indirect PPI, it was not more likely than that expected by chance ( Supplementary Fig. 26 ). However, in assessing both GWS and suggestive variants outside the HLA region, we observed a direct PPI network consisting of nine proteins with six direct interactions (P = 0.0007) and a mean associated protein direct connectivity of 1.33 (expected, 0.63; P = 0.048), as well as an indirect network that exhibited a mean associated protein indirect connectivity that trended toward significance (P = 0.082) ( Supplementary Figs. 27 and 28) . Pathway analysis in GePS for the six GWS loci outside the HLA region found enrichment in immune signal transduction pathways (3/269 genes; P = 1.54 × 10 −3 ) and IL-12 signaling pathways (2/7 genes; P = 3.80 × 10 −5 ), primarily because of the influence of IL12A and STAT4. Adding the remaining 23 loci that demonstrated suggestive association yielded similar results, with a dominance of IL-12-dependent and STAT4-dependent signaling (P = 1.63 × 10 −6 ). Assessing gene involvement in disease processes using Medical Subject Headings (MeSH) showed significant enrichment in multiple immunologically mediated diseases, including non-Hodgkin lymphoma ( 
DISCUSSION
In this study we replicated previous associations with Sjögren's syndrome in the HLA region; these associations represent the strongest genetic risk factors, with odds ratios (ORs) ~3.5. Our results are consistent with a meta-analysis of 23 case-control studies from diverse ancestral populations evaluating class II loci in Sjögren's syndrome, which also identified HLA-DQA1*0501, HLA-DQB1*0201 and HLA-DRB*0301 as disease risk factors 11 . We found associated variants in this study with P meta < 5 × 10 −5 to be enriched within 100 bp of the RFX5 ChIP-seq peaks identified by ENCODE 17 . Mutations in RFX5 can lead to the inability to transcribe class II HLA molecules and bare lymphocyte syndrome 20 . In Sjögren's syndrome, several risk alleles in or near the RFX5 ChIP-Seq peaks in the class II region were eQTLs ( Fig. 3a-e ), indicating that this transcription factor may have a critical pathogenic role. Moreover, we identified eQTLs in the class I region with additional HLA molecules, including HLA-C, HLA-A, HLA-H and HLA-G, and previous studies have found that RFX5 regulates the expression of these loci 21 . Extensive LD between variants in the HLA region may influence the enrichment analysis performed in GenomeRunner when using all variants as background; however, we continued to observe enrichment when focusing on the HLA region only. Although we cannot rule out completely the influence of LD on these results, the observation that several of these variants are eQTLs further suggests biological relevance. Although HLA class II molecules have been classically implicated in Sjögren's syndrome risk, effects of HLA class I loci have also been reported 22 . This suggests that the risk attributed to the HLA region may involve altered expression of multiple genes residing in this region and that are important to the immune system. However, it is probable that other mechanisms, such as amino acid changes similar to those implicated in rheumatoid arthritis 23 , are involved in the genetic pathophysiology of this region. Comparing the effect sizes for the two primary HLA associations with those in other autoimmune diseases, we found that the effect sizes in Sjögren's syndrome appear to be stronger than those in SLE and rheumatoid arthritis, similar to those in multiple sclerosis and weaker than those in celiac disease, type 1 diabetes and psoriasis (Supplementary Fig. 29 ).
This study also established IRF5-TNPO3, STAT4, IL12A, FAM167A-BLK, DDX6-CXCR5 and TNIP1 as risk loci. IRF5 is a transcription factor that mediates type I interferon responses in monocytes, dendritic cells and B cells 24 and induces the transcription of interferon-α genes and the production of proinflammatory cytokines (including IL-12p40, IL-6 and TNF-α) 25 after viral infection. IRF5 is an established risk locus in SLE, rheumatoid arthritis, ulcerative colitis, primary biliary cirrhosis (PBC) and systemic sclerosis [26] [27] [28] [29] [30] [31] [32] [33] . In SLE, association with three independent functional alleles has been observed 34 , which is similar to the effects described in this study. Previous studies in Sjögren's syndrome have also implicated IRF5 as a risk locus, but only ~15 variants have been tested, with a CGGGG indel polymorphism yielding the most statistically significant result and appearing to be responsible for the association at the promoter region ( Supplementary Table 1 ) 13, 15, 35, 36 . Although we were unable to impute the CGGGG indel, SNP rs2004640, which is correlated (r 2 = 0.7) with the CGGGG indel 36 , demonstrated association (P meta = 8.86 × 10 −15 ). Moreover, a three-variant haplotype, consisting of rs3757385, rs2004640 and rs10954213, perfectly tags the CGGGG indel 37, 38 . Adjusting logistic regression models for these three variants showed significant residual association (P = 1.05 × 10 −7 ) at rs3757387. After adding rs3757387, we observed a residual association (P = 1.64 × 10 −4 ) at rs17339836, suggesting that adjusting for the three-SNP haplotype tagging the CGGGG indel was equivalent to adjusting for only rs10954213. Additional studies will be necessary to determine the precise causal variant in the IRF5 promoter region.
STAT4 is critical for cellular responses that are initiated by type I interferons and is subsequently induced by IL-12 in lymphocytes, leading to the transcription of interferon-γ (ref. 39 ). Association of variants in the third intron of STAT4 has been well established in other inflammatory diseases 32, [40] [41] [42] and has also been implicated in Sjögren's syndrome ( Supplementary Table 1 ) 12, 14, 15, 43 . The variants reported in these previous studies are highly correlated (r 2 > 0.95) with the associated variant rs10553577 that we identified in this study.
IL12A encodes the p35 subunit that forms the IL-12 heterodimer, with the p40 subunit being encoded by IL12B 44 . IL-12, an immunomodulatory cytokine that is secreted primarily by monocytes and dendritic cells, has a critical role in T helper type 1 cell differentiation and the production of interferon-γ by T cells and natural killer cells 45 . Although no studies in Sjögren's syndrome have reported association with the IL12A region, several studies in related conditions have identified variants near IL12A that increase disease risk. Association of variants in the 3′ end of IL12A have been reported for PBC, and 5′ effects have been described for celiac disease [46] [47] [48] . Interestingly, the variants reported in PBC showed weak correlations (r 2 < 0.35) with the top SNP in Sjögren's syndrome, and analyses adjusting for variants identified in related diseases continued to exhibit residual association (P residual < 0.05) at rs485497. Moreover, rs574808, rs495499 and rs6441286, the most statistically significant variants in PBC 42, 46 , are highly correlated with the eQTL polymorphism reported in this study. Previous studies observed only suggestive association with the block encompassing the coding region of this gene, which includes the top overall associated variant, rs485497, in this study. Thus, the effect in the IL12A region in Sjögren's syndrome appears to be at least partially distinct from that in PBC.
IRF5, IL12A and STAT4 all participate in type I interferon pathway signaling. A role for type I interferon pathway dysregulation in Sjögren's syndrome has been described through mRNA gene expression microarray studies of labial salivary glands and peripheral npg A r t i c l e s blood 8, 9, 49, 50 . Moreover, previous work has shown that overexpression of type I interferon-inducible genes correlates with titers of the classic Sjögren's syndrome autoantibodies to Ro and La 9 . Genetic effects in Sjögren's syndrome potentially influence both subunits of IL-12. IRF5 can stimulate transcription of IL12B, and we also identified variants in the IL12A region as risk factors in this study. Once secreted from dendritic or natural killer cells, IL-12 binds T cell receptors, thereby initiating a signaling cascade through STAT4 phosphorylation 44 .
BLK is a nonreceptor Src family tyrosine kinase that is involved in B cell-receptor signaling and B-cell development. B cell-receptor signaling is essential for proper immune function, deletion of autoreactive B cells and subsequent receptor editing 51, 52 . Variants in the BLK locus have been reported to influence the expression of both FAM167A and BLK and are associated with related diseases such as SLE 53, 54 . Previous studies have implicated this region in Sjögren's syndrome risk, with the peak association observed at rs12549796 within FAM167A 14 , whereas here we identified the shared promoter region and the first intron of BLK as having the most statistically significant associations ( Fig. 2e) .
CXCR5, a membrane-bound protein that is present on some memory B cells and follicular helper T cells, acts as a receptor for B-lymphocyte chemoattractant (BLC). Variants in the CXCR5 region have been associated with multiple sclerosis and PBC 42, 55 . Although no genetic associations between Sjögren's syndrome and CXCR5 have been reported, several studies have found CXCR5 to be dysregulated in B cells in salivary gland tissues and the periphery 49, 56 . Interestingly, IL-12 alone can induce CXCR5 expression, leading to the early commitment of naive CD4 + T cells to the T follicular helper cell lineage 57 .
Although the exact function of TNIP1 has not been defined, it does bind TNFAIP3, which suppresses TLR-induced apoptosis by negatively regulating NF-κB 58 . Variants in the TNIP1 region have been found to increase risk for rheumatoid arthritis, SLE, psoriasis and systemic sclerosis [59] [60] [61] [62] [63] . In SLE, two independent risk haplotypes have been identified, with the previously defined H2 haplotype 62 corresponding to the association identified in this study. Similar to the findings reported above, the H2 haplotype in SLE also shows allelespecific differential expression 62 .
Considered jointly in the logistic regression model, the GWS and suggestively associated variants could explain a significant proportion of the heritable risk (C statistic = 0.811; Supplementary  Table 14 ). This value is higher than that of the SLE model in women of European ancestry (C statistic = 0.67) 33 . We also considered the effect size of Sjögren's syndrome-associated variants that are in LD with previously established loci achieving GWS in other autoimmune diseases. Of note, the ORs and 95% confidence intervals (CIs) for Sjögren's syndrome variants outside the HLA region ( Supplementary  Table 15 and Supplementary Fig. 30 ) are comparable to those in related autoimmune diseases, particularly with respect to SLE, with much greater variability in effect size and CI seen when considering the variants in the HLA region ( Supplementary Table 16 and Supplementary Fig. 29) .
Using bioinformatics tools, the combination of GWS and suggestively associated variants provides some evidence of direct and indirect PPI and enrichment of genes involved in immune signaling processes, particularly with respect to IL-12 and STAT4 and many autoimmune-related diseases. The importance of type I interferons has been recognized previously in the pathogenesis of Sjögren's syndrome. However, the type II interferon pathway, acting through interferon-γ downstream of IL-12 and STAT4, has now been clearly implicated by this study. In addition, multiple genes in the NF-κB pathway, including TNIP1 and TNFAIP3, support a role for this pathway in the pathogenesis of Sjögren's syndrome. Furthermore, establishing associations of several genes that are important in the adaptive immune response, including CXCR5 and BLK, as well as establishing suggestive associations in loci such as FCGR2A, provides insight into the complex genetic architecture of Sjögren's syndrome and will facilitate further studies to understand the precise functional consequences of these risk variants. Taken together, this work provides substantial progress toward explaining the genetic pathophysiology of Sjögren's syndrome, which will ultimately provide important new therapeutic targets and potential diagnostic markers, both of which are currently lacking.
In summary, we performed a large-scale genetic study of Sjögren's syndrome and established IRF5-TNPO3, STAT4, IL12A, FAM167A-BLK, DDX6-CXCR5 and TNIP1 as risk loci. We determined that there are probably multiple independent effects within the HLA and IRF5 regions. Our results also implicate 29 suggestive regions of association that warrant further study. Together these results highlight the importance of the innate and adaptive immune systems in the etiology of Sjögren's syndrome. Future work will be needed to replicate these additional candidate associations and characterize the causal variant(s) for the regions established in this study. 
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We are grateful to all the individuals with Sjögren's syndrome and those serving as healthy controls who participated in this study. We thank the following individuals for their help in the collection and ascertainment of the samples used in (ReMOAT) was used to determine the quality of the Illumina BeadArray probes 78 . Each data set was then normalized independently using robust multiarray average (RMA) 79 followed by log 2 transformation and quantile normalization. ComBat was subsequently applied to the combined data set to adjust for nonbiological experimental variation (batch effect) 80 . After QC and normalization, 15,063 probes (in 12,248 genes) were kept for further statistical analysis.
For cis-eQTL analysis, expression levels of the Sjögren's syndromeassociated genes identified in the meta-analysis of DS1 and DS2 exceeding GWS were selected for use as phenotypic traits in cis-eQTL analyses in 222 European subjects (190 cases and 32 controls). Variants associated with Sjögren's syndrome (P < 5 × 10 −5 ) in the meta-analysis flanking the target genes were evaluated for genetic association with gene expression levels using both a linear model in Matrix-eQTL 81 (using gender and disease status as covariates) and ANOVA models in Prism 6. An eQTL was considered significant if it had a false discovery rate-adjusted P value, accounting for the number of tests performed in each region, of P < 0.05. Enrichment analysis. GenomeRunner 82 was used to search for statistically significant enrichment of the set of 9,394 SNPs showing suggestive (P < 5 × 10 −5 ) or lower association with Sjögren's syndrome with annotated genomic features. Genome annotations include genes and gene prediction tracks, mRNA and EST tracks, regulation-related tracks from the ENCODE project, histone modification marks, comparative genomics tracks, structural variation and repeats tracks. GenomeRunner evaluates the null hypothesis that colocalization of a set of Sjögren's syndrome-associated SNPs with genome annotation features is not statistically significantly different from what would be observed for a random set of SNPs of the same size. Briefly, the Sjögren's syndrome-associated set of SNPs was tested for colocalization with each of the genome annotation tracks obtained from the UCSC genome database 83 for the human GRCh37/hg19 genome assembly. The whole set of 219,958 SNPs after imputation of the select regions present on the ImmunoChip array was used to randomly select an equally sized group.
Separate analyses included identification of overrepresented experimentally validated transcription factor binding sites, with a total of 148 of these sites extracted from the 'transcription factor ChIP-seq from ENCODE' track (wgEncodeRegTfbsClustered). Regions of chromatin state segmentation by HMM (hidden Markov model) from ENCODE/Broad (wgEncodeBroadH-mmGm12878HMM) were also used to assess overrepresentation of defined chromatin states containing Sjögren's syndrome-associated SNPs. Tracks of histone modifications obtained by ChIP-seq from ENCODE/Broad Institute, from ENCODE/Stanford/Yale/USC/Harvard and from ENCODE/University of Washington were used for the assessment of epigenetic marks. Unless otherwise noted, data from the GM12878 lymphoblastoid cell line were used, as the majority of the best-quality genome annotation data was obtained from this cell line. The number of Sjögren's syndrome-associated SNPs colocalized with a genome annotation track was compared with that obtained from 1,000 random simulations using a χ 2 test. Additional analyses of random sets of SNPs showed no statistically significant enrichments (data not shown). For an enrichment to be considered statistically significant, we set a Bonferroni correction threshold for 6,000 independent tests at P < 8.33 × 10 −6 .
RFX5-HLA region enrichment analysis. The HLA region was defined by the genomic coordinates chr6: 28,400,295-33,398,620 (GRCh37/hg19 human genome assembly). The number of significant SNPs in this region overlapping with RFX5 binding sites was calculated using BedTools 84 . The number of all genome-wide associated SNPs in the HLA region overlapping RFX5 binding sites was calculated and compared with the SNPs that were significantly associated with Sjögren's syndrome using Fisher's exact test (scipy.stats.fisher_exact function).
PPI. DAPPLE 18 was used to assess the potential effects of associated variants on the underlying biology. For DAPPLE, seed variants were converted to genes on the basis of variant overlap and LD structure within the region of interest. Analyses were performed using the following settings: (i) 10,000 permutations; (ii) a common interactor binding degree cutoff of 2; (iii) gene regulatory region 50 kb upstream and downstream of transcription start and end; (iv) simplification of the indirect network; and (v) iteration to prioritize genes with a Bonferroni-corrected score of P < 0.05. A total of 14 GWS variants and 114 suggestive variants were present in the DAPPLE databases; where variants were not found to be present, attempts to find proxies in high LD were made.
Pathway analysis in Genomatix. Pathway analysis was carried out using GePS 19 . This system utilizes information obtained from public and proprietary annotation databases to characterize input gene lists, determine the representation of these genes in canonical pathways and create gene networks based on co-citation of genes from the literature. The public annotation data sets incorporated in this software include Gene Ontology (GO) and MeSH, in addition to others. GePS also provides a probability statistic using Fisher's exact test to determine the likelihood of finding the number of co-represented genes with a particular annotation when considering the length of the input gene list. Input gene sets were generated using the gene locus nearest to the association signals, which were required to demonstrate suggestive or genomewide significance, and pathway analysis was carried out using the gene symbols of the input set.
